ClinicalTrials.govpublic full text
Study to Evaluate the Safety of Chronic Administration of Simulect to Subjects Receiving a First Kidney Transplant
end stage renal disease, simulect, de novo kidney transplant subjects, calcineurin inhibitors, prograf, interventional, phase2, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 873684
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.